Navigation Links
Renhuang Pharmaceuticals, Inc. Retains CCG Elite
Date:2/14/2008

LOS ANGELES and HARBIN, China, Feb. 14 /Xinhua-PRNewswire-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (OTC Bulletin Board: RHGP) ("Renhuang" or "the Company"), a leading pharmaceutical company in China, today announced that it has retained CCG Elite to design and execute its investor relations campaign.

Through its GMP certified facilities, the Company manufactures over 200 types of western, traditional Chinese medicines (TCM), and branded pharmaceuticals. The Company sells raw materials and finished products using its extensive distribution network and third party distributors throughout China. Renhuang controls an estimated 70% of China's natural source of Acanthopanax (also known as Siberian Ginseng), a widely used drug for multiple indications, and hence dominates the market for Acanthopanax-based medicinal and nutraceutical products. The Company's distribution network includes over 3,000 sales agents in 70 sales centers across 24 districts, covering over 50% of the greater China. Additionally, Renhuang exports its pharmaceuticals to Russia and Southeast Asia.

Using its strong R&D team, Renhuang performs contract research and development services. Lead pharmaceuticals include: Acanthopanax based natural medicine products for treating depression, melancholy and other illnesses, Biopharmaceuticals (Shark Power Health Care and Ginseng Ointment) for multiple indications, and TCM. For nine months ending July 31, 2007, Renhuang's revenue totaled $20.1 million, and net income was $8.5 million, up 175% from the same period in the prior year.

"Renhuang is a fast growing drug manufacturer and distributor in China," said Mr. Li Shaoming, Chairman & CEO of Renhuang Pharmaceuticals, Inc. "We are very excited to work with CCG Elite to maximize our stockholders' value by improving our visibility with the investment community and with the financial media."

Pharmaceutical sales in China are expected to increase by over 13 percent annually, rea
'/>"/>

SOURCE Renhuang Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
2. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
3. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
4. Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
5. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
6. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
7. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
8. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
9. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
10. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... September 01, 2015 , ... AthleticTraining.com, provider of CEUs for ... of new premium on-demand video Evidence Based Practice courses that ... 2014 must complete 50 CEUs before December 31, 2015, which must include at ...
(Date:8/31/2015)... ... September 01, 2015 , ... The PT Outcomes Registry ... relevant measures for physical therapy patients. The Registry is being developed by the American ... stated "We are happy to be selected to contribute FOTO Outcomes measures as one ...
(Date:8/31/2015)... NJ (PRWEB) , ... September 01, 2015 , ... ... spine to eliminate chronic back pain – once required a long, arduous recovery. ... shorter hospital stay, less pain, less blood loss and minimal muscle damage. These ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... released their latest predictive use case focused on helping hospital perform under the ... this program, hospital payments are adjusted based on performance across four domains related ...
(Date:8/31/2015)... ... August 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics proudly announces ... and Influence by Modern Luxury’s The Atlantan Magazine. , This award for ... Kathy King. Her idea and vision to bring to Atlanta a true luxury ...
Breaking Medicine News(10 mins):Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3
... WASHINGTON, July 8 As part of a clean-energy transformation, ... of its $1.4 billion in funds from the American Recovery ... energy conservation. , , "These investments help spur ... environmental footprint," Secretary of Veterans Affairs Eric K. Shinseki said. ...
... 2009 - The International Diabetes Federation (IDF), the International ... (WHF) called today on the UN,s Economic and Social ... fastest growing threat by non-communicable diseases (NCDs) to global ... cancer and chronic respiratory disease, cause 60% of all ...
... The results of a study published in the current ... the findings of a white paper released last month by ... potentially lifesaving qualities of cholesterol lowering drugs known as statins. ... established cardiovascular disease but with cardiovascular risk factors, statin use ...
... LOS ANGELES, July 8 Social Compassion in ... reducing pet overpopulation through legislation, today reported that the ... California municipal shelters increased 14.6 percent statewide - from ... recently released figures from the California Department of Public ...
... drug use, delivery made a measurable impact in Planned ... Two changes to the way Planned Parenthood clinics perform ... the rate of serious infections, a new report says. ... the area between the gum and the cheek (buccal ...
... DIEGO, July 8 Volcano Corporation (Nasdaq: VOLC ... products for the diagnosis of coronary and peripheral artery disease, ... largest distributor in Japan, Goodman Company, Ltd. This agreement, ... transition to a direct sales force in the market to ...
Cached Medicine News:Health News:Stimulus Funds Support VA Energy Conservation Efforts 2Health News:The next health tsunami: Noncommunicable diseases 2Health News:British Medical Journal Report Supports SCHS White Paper on Statins 2Health News:California Department of Public Health Reports Large Increase in Pet Euthanasia 2Health News:California Department of Public Health Reports Large Increase in Pet Euthanasia 3Health News:Changes Reduced Infections From Medical Abortion 2Health News:Changes Reduced Infections From Medical Abortion 3Health News:Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman 2Health News:Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman 3Health News:Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman 4Health News:Volcano Achieves Major Milestone in Japan Direct Sales Initiative With Signing of Termination Agreement With Goodman 5
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and the Indiana ... Forum to state legislators. The new policy forum was ... Indianapolis and featured two panel ... and State Sen. Brandt Hershman . Legislators also ... & Development Center, which is under construction on its ...
(Date:8/31/2015)... PHOENIX , Aug. 31, 2015  DICOM ... announced today that it was recognized as a ... Radiology software.  The awards are sponsored ... and related professionals in the medical imaging industry.  ... for radiology professionals to acknowledge the contributions of ...
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, ... has acquired MACTek Corporation, a leading provider of ... Pepperl+Fuchs, strategy to further extend its integrated solutions ... market.    "We are pleased to ... existing portfolio," said Jim Bolin , Pepperl+Fuchs, ...
Breaking Medicine Technology:Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... with HALO device leads to 100% patient response ... ... Calif., May 20 BARRX Medical, Inc., a global,technology leader in ... which report a 100% eradication,rate for early esophageal cancer and pre-cancerous ...
... Technologies,Inc. (Amex: PTN ) announced today that ... study of PL-3994, a novel, long-acting natriuretic peptide,receptor ... The study is placebo-controlled and double-blinded, and will ... many as 35 subjects will be,included, with six ...
Cached Medicine Technology:Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 2Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination 3Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 2Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994 3
... monitor elevates bedside glucose testing to a ... the quality of central laboratory testing. ... strip technology. Current glucose strips use ... system measures and corrects hematocrit interference as ...
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
... BreatheX is a wearable CPAP (Continuous Positive ... sleep apnea. The lightweight BreatheX CPAP device ... with its built-in, rechargeable battery, and is ... no longer need to be "plugged in ...
Paraffin Block Storage System...
Medicine Products: